154 related articles for article (PubMed ID: 206632)
1. Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex on Herpesvirus hominis infections in mice.
Olsen GA; Kern ER; Overall JC
J Infect Dis; 1978 Apr; 137(4):428-36. PubMed ID: 206632
[TBL] [Abstract][Full Text] [Related]
2. Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.
Olsen GA; Kern ER; Glasgow LA; Overall JC
Antimicrob Agents Chemother; 1976 Oct; 10(4):668-76. PubMed ID: 185951
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits.
Levy HB; Lvovsky E
J Infect Dis; 1978 Jan; 137(1):78-81. PubMed ID: 624854
[TBL] [Abstract][Full Text] [Related]
4. Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine.
Baer GM; Shaddock JH; Moore SA; Yager PA; Baron SS; Levy HB
J Infect Dis; 1977 Aug; 136(2):286-91. PubMed ID: 408427
[TBL] [Abstract][Full Text] [Related]
5. Topical polyriboinosinic-polyribocytidylic acid complex in the treatment of recurrent genital herpes.
Crane LR; Levy HB; Lerner AM
Antimicrob Agents Chemother; 1982 Mar; 21(3):481-5. PubMed ID: 7049075
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice.
Wong JP; Saravolac EG; Sabuda D; Levy HB; Kende M
Antimicrob Agents Chemother; 1995 Nov; 39(11):2574-6. PubMed ID: 8585749
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
[TBL] [Abstract][Full Text] [Related]
8. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
Kende M
J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
[TBL] [Abstract][Full Text] [Related]
10. Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.
Levy HB; Riley FL; Lvovsky E; Stephen EE
Infect Immun; 1981 Nov; 34(2):416-21. PubMed ID: 6171519
[TBL] [Abstract][Full Text] [Related]
11. A comparison of interferon responses to poly ICLC in males and females.
Bever CT; McFarlin DE; Levy HB
J Interferon Res; 1985; 5(3):423-8. PubMed ID: 2414373
[TBL] [Abstract][Full Text] [Related]
12. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
Bever CT; McFarland HF; Levy HB; McFarlin DE
Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
[TBL] [Abstract][Full Text] [Related]
13. Herpesvirus saimiri: in vitro sensitivity to virus-induced interferon and to polyriboinosinic acid: polyribocytidylic acid.
Barahona HH; Melendez LV
Proc Soc Exp Biol Med; 1971 Apr; 136(4):1163-7. PubMed ID: 4324740
[No Abstract] [Full Text] [Related]
14. Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.
Kern ER; Olsen GA; Overall JC; Glasgow LA
Antimicrob Agents Chemother; 1978 Feb; 13(2):344-6. PubMed ID: 206203
[TBL] [Abstract][Full Text] [Related]
15. Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.
Gatmaitan BG; Legaspi RC; Levy HB; Lerner AM
Antimicrob Agents Chemother; 1980 Jan; 17(1):49-54. PubMed ID: 7352750
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol
Kumaki Y; Salazar AM; Wandersee MK; Barnard DL
Antiviral Res; 2017 Mar; 139():1-12. PubMed ID: 27956136
[TBL] [Abstract][Full Text] [Related]
17. Effect of mouse interferon and polyriboinosinic acid-polyribocytidylic acid on L-cell tumor growth in nude mice.
Clercq ED
Cancer Res; 1977 May; 37(5):1502-6. PubMed ID: 856466
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.
Williams BB; Paul RT; Lerner AM
J Infect Dis; 1982 Dec; 146(6):819-25. PubMed ID: 6183371
[TBL] [Abstract][Full Text] [Related]
19. Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice.
Imanishi J; Matsubara M; Won CJ; Nomura H; Kishida T
Antimicrob Agents Chemother; 1981 May; 19(5):922-4. PubMed ID: 6170256
[TBL] [Abstract][Full Text] [Related]
20. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
Sammons ML; Stephen EL; Levy HB; Baron S; Hilmas DE
Antimicrob Agents Chemother; 1977 Jan; 11(1):80-3. PubMed ID: 402107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
